Northstar Wealth Partners’s VanEck Biotech ETF BBH Stock Holding History

Northstar Wealth Partners’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$256K	Buy	1,580 +195	+14%	+$31.7K	0.12%	122
2020 Q2	$225K	Buy	+1,385	New	+$210K	0.09%	156

Other funds holding BBH

PAG

Pinnacle Advisory Group Columbia, Maryland $2.17B AUM 39.21% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Northstar Wealth Partners's BBH Position: Q3 2020 in Review

Northstar Wealth Partners increased its VanEck Biotech ETF (BBH) stake by 14% in Q3 2020, buying an estimated $31.7K and bringing the position to 1,580 shares worth $256K. The position accounts for 0.12% of the portfolio, ranked #122.

Northstar Wealth Partners first reported a position in BBH in Q2 2020 and has held it in 2 quarters since. 101 funds tracked by Wall St. Rank hold BBH as of Q3 2020.

Northstar Wealth Partners held 1,580 shares of VanEck Biotech ETF worth $256K as of Q3 2020.
Northstar Wealth Partners bought 195 VanEck Biotech ETF shares in Q3 2020, an estimated $31.7K.
VanEck Biotech ETF made up 0.12% of Northstar Wealth Partners's portfolio in Q3 2020, its #122 holding.
Northstar Wealth Partners first reported a position in VanEck Biotech ETF in Q2 2020 and has held it in 2 quarters since.
101 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q3 2020.

Based on Northstar Wealth Partners's 13F filing for Q3 2020, filed 13 Nov 2020.